2348 — Dawnrays Pharmaceutical (Holdings) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Market Cap
HK$1.76bn
Enterprise Value
HK$737.34m
Revenue
CNY1.15bn

Annual balance sheet for Dawnrays Pharmaceutical (Holdings), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	977	932	786	993	1,067
Net Total Accounts Receivable
Net Total Receivables	511	331	368	403	322
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,715	1,549	1,511	1,744	1,720
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	596	782	1,143	1,308	1,225
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,786	2,904	3,340	3,673	3,623
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	619	480	697	932	669
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	761	733	959	1,031	768
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,026	2,171	2,381	2,642	2,855
Total Liabilities & Shareholders' Equity	2,786	2,904	3,340	3,673	3,623
Total Common Shares Outstanding